Lutetium-177 Market - Global Forecast 2026-2032

The Lutetium-177 market is becoming a core component of next-generation oncology care, driven by clinical demand for targeted radiopharmaceuticals and a focus on securing resilient supply chains. Senior decision-makers must address competitive, regulatory, and operational challenges as they position for sustained advancement in precision medicine.

Market Snapshot: Lutetium-177 Market Size and Growth

The Lutetium-177 market expanded from USD 1.05 billion in 2025 to USD 1.23 billion in 2026, with projections indicating further growth at a CAGR of 16.76% to reach USD 3.13 billion by 2032. This steady upward trend is underpinned by global interest in nuclear medicine and precision oncology, reflecting the need for reliable access to advanced theranostic solutions. Rising adoption of radiopharmaceutical therapies, especially for cancer types benefiting from targeted approaches, underscores additional supply-chain investment and operational improvements.

Lutetium-177 Market Scope & Segmentation

This report analyzes the Lutetium-177 market across strategic segments to inform informed decision-making and drive operational performance. Each segment offers unique value and supply considerations for senior leaders:

Production Routes: Evaluates carrier-added and no-carrier-added processes in terms of specific activity levels, impurity profiles, and scalable manufacturing options.
Product Forms: Differentiates between chloride Lutetium-177 for radiolabeling and ready-to-use formats, emphasizing the implications for workflow versatility and regulatory compliance.
Applications: Describes oncology uses including prostate cancer, neuroendocrine tumors, and new indications that shape clinical requirements and infrastructure planning.
End User Workflows: Reviews practices in centralized radiopharmacies, hospital nuclear medicine departments, and highly specialized cancer centers, with a focus on adapting workflows for efficiency and compliance.
Geographic Regions: Assesses the Americas, EMEA, and Asia-Pacific, focusing on how nuclear infrastructure, distribution networks, and regulations affect market access and growth.
Technology Adoption: Covers modular manufacturing, advanced automation, continuous radionuclidic purity monitoring, and digitization of the value chain to support quality and supply reliability.

Key Takeaways for Senior Decision-Makers

Securing consistent irradiation and processing resources within vertically integrated networks increasingly shapes competitive positioning across the Lutetium-177 market.
Intensified regulatory scrutiny and higher quality standards require robust radionuclidic purity and sterility protocols, along with comprehensive documentation to meet end-to-end compliance.
Long-term supply contracts, cross-industry partnerships, and data-driven logistics coordination reduce exposure to disruptions and better align suppliers with clinical delivery needs.
Service models are evolving, with differentiated offerings for therapy developers, radiopharmacies, and treatment organizations based on unique workflow and compliance demands.
Regional strategies are adjusting to reflect the development of nuclear medicine infrastructure and rising adoption of theranostics, prioritizing secure, locally managed supply and flexible logistics approaches in major markets.

Tariff Impact Across Lutetium-177 Value Chains

US tariff actions initiated in 2025 are anticipated to introduce indirect pressures on the Lutetium-177 supply chain by increasing equipment and consumable costs and complicating import processes. For producers and radiopharmaceutical firms, these regulatory changes may extend project agendas, elevate capital requirements, and mandate stricter supply partner assessments. Companies are responding with modular facility strategies, proactive supplier qualification, and contractual risk protections to address price volatility and ensure delivery continuity.

Methodology & Data Sources

The analysis integrates primary interviews with isotope production, radiopharmacy, and oncology specialists, complemented by secondary reviews of technical literature, regulatory updates, and industry disclosures. The methodology emphasizes value-chain mapping and scenario-based risk analysis to underpin strategic clarity.

Why This Report Matters

Enables leaders to benchmark their operational resilience and proactively manage the evolving impacts of technology, regulations, and regional market trends on nuclear medicine.
Delivers clear segmentation and value-chain insights that support strategic capital investment, development of robust partnerships, and clinical scale-up planning.
Clarifies risk factors such as tariff influences and tightening quality compliance—guiding more effective cost containment and ensuring continued patient access to radiopharmaceutical therapies.

Conclusion: Lutetium-177 Market Outlook

The Lutetium-177 market is advancing on the strength of validated, resilient supply models and collaborative value chain execution. Senior leaders who invest in operational agility and strategic alignment will be positioned for ongoing growth and increased clinical uptake.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Lutetium-177 Market, by Product Type

8.1. Carrier-Added Lutetium-177
8.2. No-Carrier-Added Lutetium-177

9. Lutetium-177 Market, by Production Technology

9.1. Cyclotron-Based Production
9.2. Reactor-Based Production

10. Lutetium-177 Market, by Application

10.1. Research & Preclinical
10.1.1. In Vitro Studies
10.1.2. In Vivo Animal Models
10.2. Therapeutics
10.2.1. Hematologic Malignancies
10.2.2. Neuroendocrine Tumors (SSTR)
10.2.3. Palliative Bone Metastases
10.2.4. Prostate Cancer (PSMA)

11. Lutetium-177 Market, by End-User

11.1. Hospitals
11.2. Outpatient Centers
11.3. Pharmaceutical and Biotechnology Companies
11.4. Research Institutions
11.5. Specialty Clinics

12. Lutetium-177 Market, by Distribution Channel

12.1. Direct Purchase
12.2. Indirect

13. Lutetium-177 Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Lutetium-177 Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Lutetium-177 Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Lutetium-177 Market
17. China Lutetium-177 Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Actinium Pharmaceuticals, Inc.
18.6. Bayer AG
18.7. BWX Technologies, Inc.
18.8. Cardinal Health, Inc.
18.9. China National Nuclear Corporation
18.10. Curium Pharma
18.11. Eckert & Ziegler Radiopharma GmbH
18.12. Framatome
18.13. Fusion Pharmaceuticals Inc. by AstraZeneca
18.14. IBA Radiopharma Solutions
18.15. Isotopia Molecular Imaging Ltd.
18.16. ITM Isotope Technologies Munich SE
18.17. Lantheus Holdings, Inc.
18.18. NorthStar Medical Radioisotopes, LLC
18.19. Novartis AG
18.20. NTP Radioisotopes SOC Ltd.
18.21. Nuclear Research and Consultancy Group
18.22. RadioMedix, Inc.
18.23. RayzeBio, Inc. by Bristol Myers Squibb
18.24. Revvity Inc.
18.25. SHINE Technologies, LLC
18.26. Telix Pharmaceuticals Limited

List of Figures

FIGURE 1. GLOBAL LUTETIUM-177 MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL LUTETIUM-177 MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL LUTETIUM-177 MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL LUTETIUM-177 MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL LUTETIUM-177 MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL LUTETIUM-177 MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES LUTETIUM-177 MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA LUTETIUM-177 MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL LUTETIUM-177 MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL LUTETIUM-177 MARKET SIZE, BY CARRIER-ADDED LUTETIUM-177, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL LUTETIUM-177 MARKET SIZE, BY NO-CARRIER-ADDED LUTETIUM-177, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL LUTETIUM-177 MARKET SIZE, BY CYCLOTRON-BASED PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL LUTETIUM-177 MARKET SIZE, BY REACTOR-BASED PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL LUTETIUM-177 MARKET SIZE, BY IN VITRO STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL LUTETIUM-177 MARKET SIZE, BY IN VITRO STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL LUTETIUM-177 MARKET SIZE, BY IN VITRO STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL LUTETIUM-177 MARKET SIZE, BY IN VIVO ANIMAL MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL LUTETIUM-177 MARKET SIZE, BY IN VIVO ANIMAL MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL LUTETIUM-177 MARKET SIZE, BY IN VIVO ANIMAL MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL LUTETIUM-177 MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL LUTETIUM-177 MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL LUTETIUM-177 MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL LUTETIUM-177 MARKET SIZE, BY NEUROENDOCRINE TUMORS (SSTR), BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL LUTETIUM-177 MARKET SIZE, BY NEUROENDOCRINE TUMORS (SSTR), BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL LUTETIUM-177 MARKET SIZE, BY NEUROENDOCRINE TUMORS (SSTR), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL LUTETIUM-177 MARKET SIZE, BY PALLIATIVE BONE METASTASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL LUTETIUM-177 MARKET SIZE, BY PALLIATIVE BONE METASTASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL LUTETIUM-177 MARKET SIZE, BY PALLIATIVE BONE METASTASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL LUTETIUM-177 MARKET SIZE, BY PROSTATE CANCER (PSMA), BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL LUTETIUM-177 MARKET SIZE, BY PROSTATE CANCER (PSMA), BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL LUTETIUM-177 MARKET SIZE, BY PROSTATE CANCER (PSMA), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL LUTETIUM-177 MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL LUTETIUM-177 MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL LUTETIUM-177 MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL LUTETIUM-177 MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL LUTETIUM-177 MARKET SIZE, BY OUTPATIENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL LUTETIUM-177 MARKET SIZE, BY OUTPATIENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL LUTETIUM-177 MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL LUTETIUM-177 MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL LUTETIUM-177 MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL LUTETIUM-177 MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL LUTETIUM-177 MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL LUTETIUM-177 MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL LUTETIUM-177 MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL LUTETIUM-177 MARKET SIZE, BY DIRECT PURCHASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL LUTETIUM-177 MARKET SIZE, BY DIRECT PURCHASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL LUTETIUM-177 MARKET SIZE, BY DIRECT PURCHASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL LUTETIUM-177 MARKET SIZE, BY INDIRECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL LUTETIUM-177 MARKET SIZE, BY INDIRECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL LUTETIUM-177 MARKET SIZE, BY INDIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL LUTETIUM-177 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS LUTETIUM-177 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA LUTETIUM-177 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. EUROPE LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. EUROPE LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 101. EUROPE LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 102. EUROPE LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. EUROPE LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 104. EUROPE LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 105. EUROPE LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 106. EUROPE LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. AFRICA LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. AFRICA LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 117. AFRICA LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 118. AFRICA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. AFRICA LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 120. AFRICA LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 121. AFRICA LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 122. AFRICA LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL LUTETIUM-177 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. ASEAN LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASEAN LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. ASEAN LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 135. ASEAN LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. ASEAN LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 137. ASEAN LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 138. ASEAN LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 139. ASEAN LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. GCC LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GCC LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. GCC LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 143. GCC LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. GCC LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 145. GCC LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 146. GCC LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 147. GCC LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. BRICS LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. BRICS LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. BRICS LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 159. BRICS LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. BRICS LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 161. BRICS LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 162. BRICS LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 163. BRICS LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. G7 LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. G7 LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 166. G7 LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. G7 LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. G7 LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 169. G7 LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 170. G7 LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 171. G7 LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. NATO LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. NATO LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 174. NATO LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 175. NATO LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. NATO LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 177. NATO LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 178. NATO LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 179. NATO LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES LUTETIUM-177 MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. CHINA LUTETIUM-177 MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 190. CHINA LUTETIUM-177 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. CHINA LUTETIUM-177 MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 192. CHINA LUTETIUM-177 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. CHINA LUTETIUM-177 MARKET SIZE, BY RESEARCH & PRECLINICAL, 2018-2032 (USD MILLION)
TABLE 194. CHINA LUTETIUM-177 MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 195. CHINA LUTETIUM-177 MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 196. CHINA LUTETIUM-177 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

Actinium Pharmaceuticals, Inc.
Bayer AG
BWX Technologies, Inc.
Cardinal Health, Inc.
China National Nuclear Corporation
Curium Pharma
Eckert & Ziegler Radiopharma GmbH
Framatome
Fusion Pharmaceuticals Inc. by AstraZeneca
IBA Radiopharma Solutions
Isotopia Molecular Imaging Ltd.
ITM Isotope Technologies Munich SE
Lantheus Holdings, Inc.
NorthStar Medical Radioisotopes, LLC
Novartis AG
NTP Radioisotopes SOC Ltd.
Nuclear Research and Consultancy Group
RadioMedix, Inc.
RayzeBio, Inc. by Bristol Myers Squibb
Revvity Inc.
SHINE Technologies, LLC
Telix Pharmaceuticals Limited

Table Information

Report Attribute	Details
No. of Pages	196
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 1.23 Billion
Forecasted Market Value ( USD ) by 2032	$ 3.13 Billion
Compound Annual Growth Rate	16.7%
Regions Covered	Global
No. of Companies Mentioned	22

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Lutetium-177 Market Size and Growth

Lutetium-177 Market Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact Across Lutetium-177 Value Chains

Methodology & Data Sources

Why This Report Matters

Conclusion: Lutetium-177 Market Outlook

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Radioligand Therapy (RLT) Market by Product (Lutetium-177 Vipivotide Tetraxetan, (Lu-177)- PNT2002, Radium-223 dichloride), Target (PSMA, SSTR, Bone Metastases), Indication (Prostate Cancer, Neuroendocrine Tumors (NETS), SCLC) - Global Forecast to 2035

Targeted SSTR Radionuclide Drug Conjugates Market - Global Forecast 2026-2032

Radioligand Therapy Market - Global Strategic Business Report

Targeted Radionuclide Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

Neuroendocrine Tumors Drug Pipeline Analysis Report 2025